Identifying a precise genetic cause of hearing loss impacts clinical management. Nicole Boczek, Ph.D., and Melanie Meyer, M.S., CGC, explain how Mayo Clinic Laboratories' updated panel yields comprehensive results for optimal patient care.

(00:31)
 Can you tell us a little about yourselves and your backgrounds?

(01:52)
 Could you provide a brief overview of this assay?

(02:29)
 Can the diagnosis lead to improved patient care? 

(03:51)
 When should this test be used?

(05:25)
 How do the results for AHLP alter medical management?

(07:34)

How does our AHLP compare to the market?

(08:31)

Does Mayo Clinic Laboratories' increased gene count make a difference in diagnosis?

(09:21)
 Why did we choose this many genes?

(10:02)
 When does genetics fit into a patient's journey?

(10:58)
 What are the benefits of doing AHLP at Mayo?